Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

First Rounder: Colin Goddard

First Rounder: Colin Goddard

FromFirst Rounders


First Rounder: Colin Goddard

FromFirst Rounders

ratings:
Length:
58 minutes
Released:
May 28, 2015
Format:
Podcast episode

Description

Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover. Hosted on Acast. See acast.com/privacy for more information.
Released:
May 28, 2015
Format:
Podcast episode

Titles in the series (61)

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future. Hosted on Acast. See acast.com/privacy for more information.